rockville md

ROCKVILLE, Md. (MedPage Today) -- The FDA has expanded its recall of weight-loss products that contain undeclared, active ingredients including antidepressants and diuretics.

ROCKVILLE, Md. (MedPage Today) -- The FDA has revealed an expanded recall of products by the Peanut Corporation of America after a site visit to the company's Blakely, Ga., plant uncovered more strains of salmonella and violations of "good manufacturing practices."

ROCKVILLE, Md. (MedPage Today) -- Peanut Corporation of America, the company at the center of the ongoing salmonella outbreak, distributed peanut butter that had tested positive for the bacteria, according to the FDA.

ROCKVILLE, Md. (MedPage Today) -- Peanut butter and peanut paste made at Peanut Corporation of America's processing center in Blakely, Ga., are responsible for the ongoing nationwide salmonella outbreak, the FDA announced.

ROCKVILLE, Md. (MedPage Today) -- Consumers should not eat any products containing peanut butter until they can be cleared of a connection to the ongoing nationwide salmonella outbreak, the FDA warned.

ROCKVILLE, Md. (MedPage Today) -- The FDA has ordered off the market 25 weight-loss products that the agency said contain unapproved active drugs, excessive levels of prescription agents, or potentially harmful ingredients.

ROCKVILLE, Md. (MedPage Today) -- The Consumer Medication Information handouts that pharmacies provide with each prescription filled are not up to the standards established by a 1996 law, the FDA said.

ROCKVILLE, Md. (MedPage Today) -- Advisers to the FDA voted today to recommend to the agency that two single-agent long-acting beta2 agonist inhalers be stripped of their asthma indications.

ROCKVILLE, Md. (MedPage Today) -- A panel of FDA advisers reviewing the safety of long-acting beta agonist inhalers heard calls today from two agency staffers to ban the use of the drugs in children.

ROCKVILLE, Md. (MedPage Today) -- Long-acting beta agonists are associated with an increased risk of disease-related death and hospitalization compared with other medications used to treat the condition, according to an FDA meta-analysis.